Compass Pathways PLC (fra:5Y6) Share Price

Company Profile

Business description
Compass Pathways PLC is a mental health care company dedicated to accelerating patient access to evidence-based innovation in mental health. The company is motivated by the need to find ways to help and empower people suffering with mental health challenges who are not helped by existing therapies and are pioneering the development of a new model of psilocybin therapy, in which psilocybin is administered in conjunction with psychological support. Its focus is on treatment-resistant depression, or TRD, a subset of major depressive disorder, or MDD, comprising patients who are inadequately served by the treatment paradigm. It has developed a proprietary, high-purity polymorphic crystalline formulation of psilocybin, COMP360.
Contact
33 Broadwick Street
LondonW1F 0DQ
GBR
E: [email protected]
https://compasspathways.com
Sector
Healthcare
Stock type
Defensive
Industry
Medical Care Facilities
Fiscal Year End
31 December 2026
Employees
166

Recommended

Central bankers are likely to hold interest rates steady, but Wall Street is focused on life after Powell.

Sarah Hansen | 26 January 2026

Higher diesel prices and foreign exchange hit unit cash costs.

Jon Mills, CFA | 26 January 2026

Undervalued by 24%, this wide-moat stock is a buy now.

Phelix Lee | 26 January 2026

Index	Last price	Change	% Change
All Ordinaries	9,260.00	1.50	0.02%
CAC 40	8,131.15	11.90	-0.15%
DAX 40	24,933.08	32.37	0.13%
Dow JONES (US)	49,412.40	313.69	0.64%
FTSE 100	10,148.85	5.41	0.05%
HKSE	27,068.97	303.45	1.13%
NASDAQ	23,601.36	100.11	0.43%
Nikkei 225	53,017.71	132.46	0.25%
NZX 50 Index	13,443.49	17.25	-0.13%
S&P 500	6,950.23	34.62	0.50%
S&P/ASX 200	8,935.20	8.50	0.10%
SSE Composite Index	4,131.89	0.72	-0.02%